Andrew Huberman· PhD
Now, that's a great thing, but it creates a byproduct. It breaks things down, such that you get these ROSs, these reactive oxygen species.
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Now, that's a great thing, but it creates a byproduct. It breaks things down, such that you get these ROSs, these reactive oxygen species.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
As cells age, and in particular in very metabolically active cells, they accumulate what are called ROS's, reactive oxygen species. And as reactive oxygen species go up, ATP energy production in those cells tends to go down.